Skip to main
INSP
INSP logo

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 19%
Buy 50%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Inspire Medical Systems Inc. has seen a significant increase in advertising expenses, which rose by 34% year-over-year to a total of $100 million in 2023, demonstrating the company's commitment to driving awareness and procedural growth. The company anticipates continued spending in both direct-to-consumer advertising and expects a rise in average selling prices (ASPs) beginning in calendar year 2026, supported by improved reimbursement strategies that could enhance volume and profitability. Despite a year-to-date decline of 26% in stock price, shares have surged approximately 86% since the third quarter earnings per share announcement, indicating strong investor confidence fueled by better-than-expected performance and positive outlooks.

Bears say

Inspire Medical Systems Inc. is facing a negative outlook primarily due to a decline in advertising expenditures, with 2024 ad spend projected to decrease by 5% year-over-year, indicating potential challenges in market penetration. The launch of the new Inspire 5 product has encountered unforeseen difficulties, prompting management to lower revenue and EPS forecasts, which negatively impacts the company’s stock valuation. Additionally, reduced operating expenditures, particularly in research and development as well as selling and administrative expenses, suggest a significant scaling back of growth initiatives, further compounding concerns about future revenue generation.

INSP has been analyzed by 16 analysts, with a consensus rating of Buy. 19% of analysts recommend a Strong Buy, 50% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Buy based on their latest research and market trends.

According to 16 analysts, INSP has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $134.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $134.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.